188 related articles for article (PubMed ID: 15952911)
21. [Immunotherapy for Alzheimer's disease targeting Aβ].
Tabira T
Nihon Rinsho; 2016 Mar; 74(3):423-6. PubMed ID: 27025080
[TBL] [Abstract][Full Text] [Related]
22. [One hundred years of Alzheimer's disease: immunotherapy a hope?].
Behrens P MI; Vergara E F
Rev Med Chil; 2007 Jan; 135(1):103-10. PubMed ID: 17369991
[TBL] [Abstract][Full Text] [Related]
23. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
[TBL] [Abstract][Full Text] [Related]
24. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
Schenk DB; Seubert P; Grundman M; Black R
Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
[TBL] [Abstract][Full Text] [Related]
25. DNA Aβ42 vaccination as possible alternative immunotherapy for Alzheimer disease.
Rosenberg RN; Lambracht-Washington D
JAMA Neurol; 2013 Jun; 70(6):772-3. PubMed ID: 23700123
[No Abstract] [Full Text] [Related]
26. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
27. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
28. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
[TBL] [Abstract][Full Text] [Related]
29. Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy.
Ghochikyan A
CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):128-43. PubMed ID: 19355933
[TBL] [Abstract][Full Text] [Related]
30. Simplified β-amyloid peptides for safer Alzheimer's vaccines development.
Verdoliva A; Rivieccio V; Rossi M
Hum Vaccin; 2010 Nov; 6(11):936-47. PubMed ID: 20980800
[TBL] [Abstract][Full Text] [Related]
31. [Vaccine therapy for Alzheimer's disease].
Hara H
Nihon Rinsho; 2004 Apr; 62 Suppl 4():254-8. PubMed ID: 15174680
[No Abstract] [Full Text] [Related]
32. Alzheimer's amyloid immunotherapy: quo vadis?
Gandy S; Heppner FL
Lancet Neurol; 2005 Aug; 4(8):452-3. PubMed ID: 16033686
[No Abstract] [Full Text] [Related]
33. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
[TBL] [Abstract][Full Text] [Related]
34. Developing novel immunogens for an effective, safe Alzheimer's disease vaccine.
Maier M; Seabrook TJ; Lemere CA
Neurodegener Dis; 2005; 2(5):267-72. PubMed ID: 16909008
[TBL] [Abstract][Full Text] [Related]
35. [Amyloid-beta protein vaccine therapy for alzheimer's disease].
Hara H
Nihon Naika Gakkai Zasshi; 2006 Jun; 95(6):1122-8. PubMed ID: 16846064
[No Abstract] [Full Text] [Related]
36. Current progress in beta-amyloid immunotherapy.
Schenk D; Hagen M; Seubert P
Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's vaccine: a cure as dangerous as the disease?
Münch G; Robinson SR
J Neural Transm (Vienna); 2002 Apr; 109(4):537-9. PubMed ID: 11956972
[TBL] [Abstract][Full Text] [Related]
38. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
Boche D; Denham N; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020
[TBL] [Abstract][Full Text] [Related]
39. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
40. [Novel vaccine therapy for Alzheimer's disease--recent progress and our approach].
Okura Y; Matsumoto Y
Brain Nerve; 2008 Aug; 60(8):931-40. PubMed ID: 18717197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]